JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3%

Zacks02:54

The Joint Corp.’s JYNT shares have lost 2.7% since it reported third-quarter 2024 results. The quarterly results were hurt by an elevated general and administrative expense level. Impairment-related ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483346063?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/.cFExAtq.C.oud6sX39cog--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f21818c32cbc40e4ff1ee29342da1830","is_english":true,"pubTime":"2024-11-15 02:54","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2483346063","market":"us","top_or_hot":-1,"title":"JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3%","media":"Zacks","content":"<div>\n<p>The Joint Corp.’s JYNT shares have lost 2.7% since it reported third-quarter 2024 results. The quarterly results were hurt by an elevated general and administrative expense level. Impairment-related ...</p>\n\n<a href=\"https://finance.yahoo.com/news/jynts-q3-earnings-meet-estimates-185400831.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-15 02:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/jynts-q3-earnings-meet-estimates-185400831.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Joint Corp.’s JYNT shares have lost 2.7% since it reported third-quarter 2024 results. The quarterly results were hurt by an elevated general and administrative expense level. Impairment-related ...</p>\n\n<a href=\"https://finance.yahoo.com/news/jynts-q3-earnings-meet-estimates-185400831.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EHC","symbol_name":"Encompass Health Corporation","start_time":0,"source_url":"https://finance.yahoo.com/news/jynts-q3-earnings-meet-estimates-185400831.html","article_id":"2483346063","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/.cFExAtq.C.oud6sX39cog--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f21818c32cbc40e4ff1ee29342da1830"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483346063","pubTimestamp":1731610440,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Nevertheless, the downside was offset by higher system-wide sales, led by improved royalty fees, advertising fund revenues and software fees.JYNT reported adjusted earnings per share of 4 cents, which matched the Zacks Consensus Estimate. The bottom line compared favorably with the adjusted loss of 5 cents per share reported a year ago.Revenues improved 2% year over year to $30.2 million. The top line surpassed the consensus mark by 5.5%.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.The Joint Corp. price-consensus-eps-surprise-chart | The Joint Corp. Quote. Revenues from company-owned or managed clinics of $17.5 million dipped 1.9% year over year. Royalty fees advanced 10.2% year over year to $7.9 million in the third quarter. Advertising fund revenues were $2.2 million, up 9.6% year over year. Software fees of $1.4 million improved 10% year over year. Meanwhile, franchise fees fell 7.5% year over year to $0.7 million.The company presently estimates system-wi","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"EHC":"Encompass Health Corporation","JYNT":"The Joint Corp.","MOH":"Molina Healthcare Inc"},"translate_title":"由于成本上升，JYNT第三季度盈利符合预期，股价下跌3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JYNT":1,"EHC":0.9,"MOH":0.9},"content_text":"The Joint Corp.’s JYNT shares have lost 2.7% since it reported third-quarter 2024 results. The quarterly results were hurt by an elevated general and administrative expense level. Impairment-related charges also affected the bottom line.\nNevertheless, the downside was offset by higher system-wide sales, led by improved royalty fees, advertising fund revenues and software fees. \nJYNT reported adjusted earnings per share of 4 cents, which matched the Zacks Consensus Estimate. The bottom line compared favorably with the adjusted loss of 5 cents per share reported a year ago.\nRevenues improved 2% year over year to $30.2 million. The top line surpassed the consensus mark by 5.5%.\nStay up-to-date with all quarterly releases: See Zacks Earnings Calendar.\n\nThe Joint Corp. Price, Consensus and EPS Surprise\n  \nThe Joint Corp. price-consensus-eps-surprise-chart | The Joint Corp. Quote\n\nJYNT’s Q3 Performance\nRevenues from company-owned or managed clinics of $17.5 million dipped 1.9% year over year. Royalty fees advanced 10.2% year over year to $7.9 million in the third quarter. Advertising fund revenues were $2.2 million, up 9.6% year over year. Software fees of $1.4 million improved 10% year over year. Meanwhile, franchise fees fell 7.5% year over year to $0.7 million. \nTotal cost of revenues amounted to $2.8 million, which escalated 8.4% year over year due to increased regional developer royalties and commissions. General and administrative expenses increased 2.7% year over year to $20.8 million. However, total selling, general and administrative costs dipped 0.4% year over year to $26.8 million.  \nThe Joint incurred a net loss of $3.2 million, wider than the prior-year quarter’s net loss of $0.7 million due to a loss incurred on disposition or impairment. \nSystem-wide sales rose 8% year over year to $129.3 million. As of Sept. 30, 2024, the company’s total clinic count was 963, lower than the Zacks Consensus Estimate of 975. The number of franchised clinics totaled 838, which was lower than the consensus mark of 864. Yet, company-owned or managed clinics were 125, higher than the consensus estimate of 111.\nAdjusted EBITDA tumbled 16% year over year to $2.4 million.\nThe Joint’s Financial Update (as of Sept. 30, 2024)\nJYNT exited the third quarter with cash and cash equivalents of $20.7 million, which increased 14.2% from the 2023-end level. \nTotal assets of $79.6 million fell 8.7% from the figure at 2023-end. \nThere was no reported debt under the credit agreement.\nTotal equity of $20.5 million declined 17.3% from the 2023-end level.\nThe Joint generated net cash from operations of $5.3 million for the first nine months ended Sept. 30, 2024, which dropped 53.2% from the prior-year period.\nThe Joint’s 2024 Guidance\nThe company presently estimates system-wide sales to be in the range of $525-$535 million, down from the prior view of $530-$545 million. \nIt expects to open 55-60 franchised clinics, down from the earlier view of 60-75.\nJYNT’s Zacks Rank\nThe Joint currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank stocks here.\nOther Medical Sector Releases\nOf the Medical sector players that have reported third-quarter 2024 results so far, the bottom-line results of Molina Healthcare, Inc. MOH, Encompass Health Corporation EHC and The Ensign Group, Inc. ENSG beat the respective Zacks Consensus Estimate.\nMolina Healthcare reported third-quarter adjusted earnings per share (EPS) of $6.01, which beat the Zacks Consensus Estimate of $5.96. Also, the bottom line grew 19% from the year-ago period. Total revenues amounted to $10.3 billion, which improved 20.9% year over year. Also, the top line outpaced the consensus mark by 3.8%. Premium revenues of $9.7 billion increased 18% year over year . \nAs of Sept. 30, 2024, total membership improved 8% year over year to around 5.6 million. Investment income rose 5.4% year over year to $118 million.  Adjusted general and administrative expense ratio decreased to 6.4% in the third quarter from 7.1% a year ago. The consolidated medical care ratio, or MCR, was 89.2% . The metric rose from 88.7% a year ago. Its adjusted net income increased 18% year over year to $347 million. \nEncompass Health reported third-quarter adjusted EPS of $1.03, which beat the Zacks Consensus Estimate by 9.6%. The bottom line increased 19.8% year over year. Net operating revenues of $1.4 billion improved 11.6% year over year. The top line beat the consensus mark by 1.7%. EHC’s net patient revenue per discharge rose 2.5% year over year. \nTotal discharges grew 8.8% year over year 62.7 million, higher than our growth estimate of 61 million.  Net and comprehensive income climbed 29.7% year over year to $147.1 million in the third quarter.  Adjusted EBITDA of $269.3 million grew 13.4% year over year and surpassed our estimate of $247.1 million. Encompass Health added 10 beds to its existing hospitals in the third quarter. It also inaugurated two de novo hospitals.\nEnsign Group reported a third-quarter adjusted EPS of $1.39, which beat the Zacks Consensus Estimate by 1.5%. The bottom line increased 15.8% year over year. Operating revenues of $1.08 billion improved 15% year over year The top line outpaced the consensus mark by 1.7%. Ensign Group’s adjusted net income grew 17.7% year over year to $81.1 million . \nSame-store occupancy improved 280 basis points (bps) year over year, while transitioning occupancy expanded 480 bps year over year. The Skilled Services segment’s revenues rose 14.4% year over year to $1 billion in the third quarter. Segment income of $128.5 million improved 9.1% year over year. Skilled nursing and campus operations of the segment totaled 282 and 29, respectively, at the third-quarter end.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nMolina Healthcare, Inc (MOH) : Free Stock Analysis Report\nThe Ensign Group, Inc. (ENSG) : Free Stock Analysis Report\nThe Joint Corp. (JYNT) : Free Stock Analysis Report\nEncompass Health Corporation (EHC) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483346063"}